Florida’s Canadian drug-import plan stalls amid industry pushback and delays

Florida’s controversial plan to import Canadian prescription drugs, once promoted by Gov. DeSantis as a cost-saving model, has stalled despite FDA authorization and more than $82 million spent on LifeScience Logistics; Canada’s pharmaceutical industry has shown little interest and warned it could jeopardize drug supply, leaving the Lakeland facility repurposed for hurricane emergency storage and the state pursuing alternative price measures as progress remains limited.